Junpeng Xie

机构：Central South University, Second Xiangya Hospital of Central South University

发表论文 4 篇 · 总被引 78 次 · h-index 2

代表论文

• Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer (2023 · Frontiers in Immunology · 被引 70)
• Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel–based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer (2023 · Frontiers in Oncology · 被引 7)
• Association of cardiovascular disease and CIRS‑G and ACE‑27 comorbidity indices with pathological complete response of non‑small cell lung cancer to neoadjuvant chemoimmunotherapy (2025 · Experimental and Therapeutic Medicine)
• Peripheral blood white blood cells, monocytes, basophils, aspartate aminotransferase, and prothrombin time ratio after two cycles of treatment were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer (2023 · Research Square)